COVID-19 associated encephalopathy responding to treatment with intravenous immunoglobulins

Česká verze

Authors: S. Ostrý ^1,2; J. Keller ³; O. Sobek ⁴; A. Chrdle ^5,6,7; R. Rusina ⁸
Authors place of work: Neurologické oddělení, Nemocnice České Budějovice, a. s. ¹; Neurochirurgická a neuroonkologická klinika 1. LF UK a ÚVN – VFN Praha ²; Radiodiagnostické oddělení, Nemocnice, Na Homolce, Praha ³; Laboratoř pro likvorologii, neuroimunologii, patologii a speciální diagnostiku, Topelex s. r. o., Praha ⁴; Infekční oddělení, Nemocnice České Budějovice, a. s. ⁵; Royal Liverpool University Hospital, Liverpool, Velká Británie ⁶; Zdravotně sociální fakulta Jihočeské univerzity v Českých Budějovicích ⁷; Neurologická klinika 3. LF UK a Thomayerova nemocnice, Praha ⁸
Published in the journal: Cesk Slov Neurol N 2020; 83/116(6): 640-642
Category: Dopis redakci
doi: https://doi.org/10.48095/cccsnn2020640

Zdroje

1. Paterson RW, Brown RL, Benjamin L et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 2020; 143 (10): 3104–3120. doi: 10.1093/brain/awaa240.

2. Dogan L, Kaya D, Sarikaya T et al. Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series. Brain 2020; 87: 155–158. doi: 10.1016/j.bbi.2020.05.022.

3. Cao A, Rohaut B, Guennec LL et al. Severe COVID-19-related encephalitis can respond to immunotherapy. Brain 2020 [ahead of print]. doi: 10.1093/brain/awaa337.

4. Rodriguez M, Soler Y, Perry M et al. Impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the nervous system: implications of COVID-19 in neurodegeneration. Front Neurol 2020; 11: 583459. doi: 10.3389/fneur.2020.583459.

5. Sharifian-Dorche M, Huot P, Osherov M et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci 2020; 417: 117085. doi: 10.1016/j.jns.2020.117085.

6. Ellul MA, Benjamin L, Singh B et al. Neurological associations of COVID-19. Lancet Neurol 2020; 19 (9): 767–783. doi: 10.1016/S1474-4422 (20) 30221-0.

7. Meppiel E, Peiffer-Smadja N, Maury A et al. Neurological manifestations associated with COVID-19: a multicentric registry. Clin Microbiol Infect 2020 [ahead of print]. doi: 10.1016/j.cmi.2020.11.005.

8. Otruba P, Bardoň J, Kolář M et al. Neurologické komplikace koronavirové infekce SARS-CoV-2 (COVID-19). Neurol Praxi 2020; 21 (Suppl G): 3–14.

9. Diez JM, Romero C, Vergara-Alert J et al. Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins. Immunotherapy 2020; 12 (17): 1247–1255. doi: 10.2217/imt-2020-0220.

10. Tang Y, Liu J, Zhang D et al. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol 2020; 11: 1708. doi: 10.3389/fimmu.2020.01708.